Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Lymphoma, Large B-Cell, Diffuse 10Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Lymphoma, B-Cell 9Lymphoma, Non-Hodgkin 7Recurrence 6Multiple Myeloma 4Leukemia, Myeloid, Acute 4Lymphoma, Mantle-Cell 3Lymphoma 3Burkitt Lymphoma 3Lymphoma, Follicular 2Solid Tumors 1Sarcoma, Synovial 1Sarcoma, Ewing 1Sarcoma 1Rhabdomyosarcoma 1Pyloric Stenosis, Hypertrophic 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Platinum-Resistant Ovarian Carcinoma 1Plasmacytoma 1Pancreatic Neoplasms 1Osteosarcoma 1Neoplasms 1Neoplasm, Residual 1Nasopharyngeal Carcinoma 1Lymphoma, B-Cell, Marginal Zone 1Liver Neoplasms 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, B-Cell 1

Interventions

Immunotherapy, Adoptive 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Immunotherapy × Immunotherapy, Adoptive × Clear all
NCT05354375 2022-04-29

Clinical Study of PSMA-targeted CAR-T Cells in the Treatment of Castration-resistant Prostate Cancer

The Affiliated Hospital of Xuzhou Medical University

Phase 1 Recruiting
20 enrolled

Immunotherapy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡